[go: nahoru, domu]

Latest News for: rna

Edit

HuidaGene Therapeutics Receives the First-Ever FDA Clearance of CRISPR/Cas13 RNA-Editing HG202 for Macular Degeneration

PR Newswire 04 Nov 2024
FDA has cleared its investigational new drug (IND) application for HG202, the world's first-ever CRISPR/Cas13 RNA-editing therapy for clinical use in treating neovascular age-related macular degeneration (nAMD), which affects millions worldwide.
Edit

The DNA/RNA Sample Extraction and Isolation Market: Trends, Drivers, and Future.. (BIS Research)

Public Technologies 01 Nov 2024
) The DNA/RNA Sample Extraction and Isolation Market. Trends, Drivers, and Future Prospects BIS Research Nov 1, 2024 12.40.11 PM The DNA/RNA Sample Extraction ...
Edit

Discover the Future of RNA with NTx at Upcoming Industry Events

Business Wire 01 Nov 2024
RIO RANCHO, N.M.--(BUSINESS WIRE)--NTx senior leadership will attend a lineup of industry conferences throughout November and December to preview its NTxscribe system ... .
Edit

Zika Virus Therapeutics Market Research 2024-2030: Growing Use Of RNA-Based Therapeutics In Treatment Expands Opportunities

MENA FN 01 Nov 2024
(MENAFN - GlobeNewsWire - Nasdaq) Dublin, Nov. 01, 2024 (GLOBE NEWSWIRE) -- The "Zika Virus Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's ... .
Edit

RNA sequencing approach offers real-time and programmable transcriptome sequencing

Phys Dot Org 01 Nov 2024
Conventional targeted RNA-seq methods often require labor-intensive pre-sequencing enrichment steps, which can compromise comprehensive transcriptome profiling and limit their broader applications.
Edit

Discovery of a protein's key role in RNA processes could improve disease treatment in humans ...

Phys Dot Org 01 Nov 2024
This target centers on RNA regulation, which, when disrupted in humans, is often linked to neurodegenerative diseases like Alzheimer's disease and Parkinson's disease, as well as many types of cancer ... RNA's role in plant and human health.
Edit

Doctor warns new self-replicating RNA vaccines being rolled out in Japan are “the third atomic bomb”

Natural News 31 Oct 2024
The initial round of COVID-19 vaccines were ineffective, dangerous and downright scary, but now Big Pharma has managed to come up with something even... .
Edit

Discovery of a protein’s key role in RNA processes could improve disease treatment in humans ...

The Bryan Eagle 31 Oct 2024
Texas A&M AgriLife biochemists identify potential target to regulate RNA gene expressionThe post Discovery of a protein’s key role in RNA processes could improve disease treatment in humans and plants appeared first on AgriLife Today ....
Edit

Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs Form 8 K (Wave Life Sciences Ltd)

Public Technologies 31 Oct 2024
Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs ... Wave plans to have five GalNAc-RNA editing or GalNAc-siRNA programs in the clinic by 2026.
Edit

Geneyx and Ocean Genomics Announce SVDuo™ Release, Delivering Integrated DNA and RNA Analysis to Enhance Genomic Variant Detection for Research and Clinical Genomics

PR Newswire 30 Oct 2024
This advancement combines DNA and RNA analysis to enhance the detection of genomic variants, advancing disease diagnosis and the discovery of biomarkers and drug targets.
Edit

The Third Atomic Bomb: Self-replicating RNA vaccines

The Exposé 29 Oct 2024
While he was there, a large crowd were protesting the roll-out of the new self-replicating RNA vaccines which the Japanese are referring to as “the third atomic bomb.” ... self-replicating RNA vaccines.
Edit

RiboX Therapeutics Announces FDA Clearance for IND Application of RXRG001, the First Circular RNA Therapy for the Treatment of Radiation-Induced Xerostomia and Hyposalivation

PR Newswire 25 Oct 2024
RXRG001 is the first-ever circular RNA therapy to receive FDA IND clearance. This important advancement marks a significant milestone as circular RNA drugs advance into the clinical development phase.
Edit

The cellular superhero that protects us against RNA viruses

Science Daily 24 Oct 2024
... RNA viruses, such as influenza viruses, coronaviruses, or Zika virus.

Most Viewed

×